EMX2OS has shown significant diagnostic and prognostic value in a variety of cancers, such as gastric cancer and renal clear cell carcinoma, where its expression level is significantly correlated with patient grade, stage and cancer status (22, 23). This evidence concerns the gene EMX2OS and cancer.